Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Thoracic 1CNS 1Breast 1

Conditions

Small Cell Lung Carcinoma 1Multiple Sclerosis 1Lymphopenia 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Fingolimod Hydrochloride × Clear all
NCT06424067 2026-03-30

Phase 2 Study of Fingolimod in Lung Cancers

Medical University of South Carolina

Phase 2 Recruiting
38 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT03941743 2023-07-21

Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer

Mayo Clinic

Phase 1 Completed
2 enrolled
Breast

Breast Neoplasms

NCT02939079 2019-05-14

Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients

Isfahan University of Medical Sciences

Phase 2/3 Completed
50 enrolled 20 charts

Multiple Sclerosis

NCT02490930 2017-09-13

A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Completed
5 enrolled
CNS

Astrocytoma, Glioblastoma, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡